Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms.

British Journal of Haematology
Maki OkuNorimitsu Kadowaki

Abstract

Oncolytic viruses exert an anti-tumour effect through two mechanisms: direct oncolytic and indirect immune-mediated mechanisms. Although oncolytic herpes simplex virus type 1 (HSV-1) has been approved for melanoma treatment and is being examined for its applicability to a broad spectrum of malignancies, it is not known whether it has an anti-myeloma effect. In the present study, we show that the third-generation oncolytic HSV-1, T-01, had a direct oncolytic effect on five of six human myeloma cell lines in vitro. The anti-tumour effect was enhanced in the presence of peripheral blood mononuclear cells (PBMCs) from healthy individuals and, to a lesser extent, from patients with myeloma. The enhancing effect of PBMCs was abrogated by blocking type I interferons (IFNs) or by depleting plasmacytoid dendritic cells (pDCs) or natural killer (NK) cells, suggesting that pDC-derived type I IFNs and NK cells dominated the anti-tumour effect. Furthermore, the combination of T-01 and lenalidomide exhibited enhanced cytotoxicity, and the triple combination of T-01, lenalidomide and IFN-α had a maximal effect. These data indicate that oncolytic HSV-1 represents a viable therapy for plasma cell neoplasms through direct oncolysis and immune ac...Continue Reading

References

Jul 19, 2000·The Journal of Experimental Medicine·N KadowakiY J Liu
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·T TodoP A Johnson
Jan 11, 2005·British Journal of Haematology·Toshiaki HayashiKenneth C Anderson
Feb 9, 2012·Advances in Virology·Swarna BaisChristopher R Cogle
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Dec 17, 2014·Immunological Reviews·Yawara KawanoIrene M Ghobrial
Feb 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shaji K Kumar, Kenneth C Anderson
Apr 15, 2017·Frontiers in Immunology·Lena MüllerDagmar Stoiber
Nov 23, 2017·Frontiers in Immunology·Gianfranco PittariBenedetto Bruno
Dec 7, 2017·Blood Cancer Journal·Daniel E MeyersDon G Morris
Feb 28, 2018·Frontiers in Immunology·Hong-Sheng Dai, Michael A Caligiuri
May 11, 2018·Nature Reviews. Immunology·Praveen K BommareddyHoward L Kaufman
Jul 3, 2019·Journal for Immunotherapy of Cancer·Louise M E MüllerFiona Errington-Mais

❮ Previous
Next ❯

Citations

Mar 20, 2021·Molecular Therapy Oncolytics·Jayeeta GhoseFlavia Pichiorri
Apr 25, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chen YangXiangmin Tong
Oct 29, 2021·Journal of Clinical and Experimental Hematopathology : JCEH·Norimitsu Kadowaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Ryo IshinoNorimitsu Kadowaki
Current Cancer Drug Targets
Hiroshi Fukuhara, Tomoki Todo
Advances in Experimental Medicine and Biology
Tomoki Todo
© 2021 Meta ULC. All rights reserved